| Daniel Joseph Slade, | |
|
1210 W Faris Rd, Greenville, SC 29605-4444 | |
| (864) 522-1800 | |
| (864) 522-1806 |
| Full Name | Daniel Joseph Slade |
|---|---|
| Gender | Male |
| Speciality | Radiology - Neuroradiology |
| Location | 1210 W Faris Rd, Greenville, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013404847 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 82718 (South Carolina) | Primary |
| Entity Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the "in press" section of the journal Ophthalmology.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Molecular diagnostics company Insight Genetics and Kindstar Globalgene Technology, Inc., China's leading diagnostics company, today announced that the companies are partnering to enhance cancer care in the People's Republic of China and surrounding regions.
Researchers from the United States have found that public may be under a mistaken belief regarding the efficacy of commercially available drugs and drug promotions and bias may be the reason behind this.
It's human nature to hate losing. Unfortunately, it's also human nature to overreact to a loss, potentially abandoning a solid strategy and thus increasing your chances of losing the next time around.
› Verified 1 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568799955 PECOS PAC ID: 8325950983 Enrollment ID: O20040108000041 |
News Archive
A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the "in press" section of the journal Ophthalmology.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Molecular diagnostics company Insight Genetics and Kindstar Globalgene Technology, Inc., China's leading diagnostics company, today announced that the companies are partnering to enhance cancer care in the People's Republic of China and surrounding regions.
Researchers from the United States have found that public may be under a mistaken belief regarding the efficacy of commercially available drugs and drug promotions and bias may be the reason behind this.
It's human nature to hate losing. Unfortunately, it's also human nature to overreact to a loss, potentially abandoning a solid strategy and thus increasing your chances of losing the next time around.
› Verified 1 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730786096 PECOS PAC ID: 8325950983 Enrollment ID: O20201029000932 |
News Archive
A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the "in press" section of the journal Ophthalmology.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Molecular diagnostics company Insight Genetics and Kindstar Globalgene Technology, Inc., China's leading diagnostics company, today announced that the companies are partnering to enhance cancer care in the People's Republic of China and surrounding regions.
Researchers from the United States have found that public may be under a mistaken belief regarding the efficacy of commercially available drugs and drug promotions and bias may be the reason behind this.
It's human nature to hate losing. Unfortunately, it's also human nature to overreact to a loss, potentially abandoning a solid strategy and thus increasing your chances of losing the next time around.
› Verified 1 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the "in press" section of the journal Ophthalmology.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Molecular diagnostics company Insight Genetics and Kindstar Globalgene Technology, Inc., China's leading diagnostics company, today announced that the companies are partnering to enhance cancer care in the People's Republic of China and surrounding regions.
Researchers from the United States have found that public may be under a mistaken belief regarding the efficacy of commercially available drugs and drug promotions and bias may be the reason behind this.
It's human nature to hate losing. Unfortunately, it's also human nature to overreact to a loss, potentially abandoning a solid strategy and thus increasing your chances of losing the next time around.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Joseph Slade, 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Daniel Joseph Slade, 1210 W Faris Rd, Greenville, SC 29605-4444 Ph: (864) 522-1800 |
News Archive
A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the "in press" section of the journal Ophthalmology.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Molecular diagnostics company Insight Genetics and Kindstar Globalgene Technology, Inc., China's leading diagnostics company, today announced that the companies are partnering to enhance cancer care in the People's Republic of China and surrounding regions.
Researchers from the United States have found that public may be under a mistaken belief regarding the efficacy of commercially available drugs and drug promotions and bias may be the reason behind this.
It's human nature to hate losing. Unfortunately, it's also human nature to overreact to a loss, potentially abandoning a solid strategy and thus increasing your chances of losing the next time around.
› Verified 1 days ago
Bonnie Louise Anderson, MD Radiology Medicare: Medicare Enrolled Practice Location: 1210 W Faris Rd, Greenville, SC 29605 Phone: 864-295-4410 Fax: 864-295-5694 | |
Dr. Douglas Middleton Bull, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1210 W Faris Rd, Greenville, SC 29605 Phone: 864-522-1800 Fax: 864-522-1806 | |
Dr. Mark R Jackson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3 Saint Francis Dr, Suite 330, Greenville, SC 29601 Phone: 864-255-1834 Fax: 864-255-1836 | |
Dr. Michael Franklin Brinkley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1210 W Faris Rd, Greenville, SC 29605 Phone: 864-522-1800 Fax: 864-522-1806 | |
Matthew Timothy Graham, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3 Saint Francis Dr Ste 360, Greenville, SC 29601 Phone: 864-233-4349 Fax: 877-417-0311 | |
Dr. Michael David Zurenko, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 65 International Dr, Greenville, SC 29615 Phone: 864-987-7000 Fax: 864-987-7020 |